Oscar Health (OSCR) Cost of Revenue (2020 - 2026)

Oscar Health (OSCR) has 7 years of Cost of Revenue data on file, last reported at $3.2 billion in Q1 2026.

• Quarterly Cost of Revenue rose 42.94% year-over-year to $3.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 billion (up 36.73% YoY) and the FY2025 annual result came in at $10.0 billion, up 36.64% from the prior year.
• Cost of Revenue improved to $3.2 billion in Q1 2026, from $2.6 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.2 billion in Q1 2026 to a low of $734.6 million in Q1 2022.
• A 5-year average of $1.7 billion and a median of $1.6 billion in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue jumped 174.04% — and 2025, when it grew 26.87%.
• Tracing OSCR's Cost of Revenue over 5 years: stood at $884.9 million in 2022, then soared by 36.2% to $1.2 billion in 2023, then soared by 71.34% to $2.1 billion in 2024, then rose by 26.87% to $2.6 billion in 2025, then rose by 23.27% to $3.2 billion in 2026.
• The last three Cost of Revenue figures came in at $3.2 billion (Q1 2026), $2.6 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.